ValiRx plc (LON:VAL – Get Free Report) crossed below its 200-day moving average during trading on Friday . The stock has a 200-day moving average of GBX 0.25 and traded as low as GBX 0.15. ValiRx shares last traded at GBX 0.17, with a volume of 81,020,672 shares changing hands.
ValiRx Price Performance
The company’s 50 day moving average price is GBX 0.17 and its 200 day moving average price is GBX 0.25. The company has a debt-to-equity ratio of 0.05, a quick ratio of 1.27 and a current ratio of 4.62. The company has a market cap of £2.24 million, a price-to-earnings ratio of -0.31 and a beta of 0.59.
ValiRx (LON:VAL – Get Free Report) last announced its earnings results on Monday, June 22nd. The company reported GBX (0.54) earnings per share (EPS) for the quarter. ValiRx had a negative return on equity of 70.79% and a negative net margin of 7,115.36%.The firm had revenue of GBX 3 million for the quarter. On average, equities research analysts predict that ValiRx plc will post -1.74 earnings per share for the current fiscal year.
About ValiRx
ValiRx accelerates the development of treatments in cancer and women’s health to improve patient lives. We provide the scientific, financial and commercial framework to enable the rapid translation of innovative science into clinical development.
Featured Stories
- Five stocks we like better than ValiRx
- Take-Two’s Q1 Results Leave GTA 6 Bulls Stuck in the Fog of War
- AI Cold War Catches Light: Federal Friction in the Server Rack
- 3 Stocks Whose Charts May Be Signaling the Next Big Move
- Quantum Earnings Week: Winners and Losers Are Finally Emerging
Receive News & Ratings for ValiRx Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ValiRx and related companies with MarketBeat.com's FREE daily email newsletter.
